DOCSLIB.ORG

Heterogeneity of PD-L1 Expression and CD8 Tumor-Infiltrating

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Heterogeneity of PD-L1 Expression and CD8 Tumor-Infiltrating Cancer Immunology, Immunotherapy (2019) 68:951–960 https://doi.org/10.1007/s00262-019-02334-8 ORIGINAL ARTICLE Heterogeneity of PD‑L1 expression and CD8 tumor‑infltrating lymphocytes among subtypes of cutaneous adnexal carcinomas Lucie Duverger1 · Amélie Osio1 · Bernard Cribier2 · Laurent Mortier3 · Adèle De Masson4,5 · Nicole Basset‑Seguin4,5 · Céleste Lebbé4,5 · Maxime Battistella1,6 Received: 15 September 2018 / Accepted: 28 March 2019 / Published online: 5 April 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Background Adnexal carcinomas are rare and heterogeneous skin tumors, for which no standard treatments exist for locally advanced or metastatic tumors. Aim of the study To evaluate the expression of PD-L1 and CD8 in adnexal carcinomas, and to study the association between PD-L1 expression, intra-tumoral T cell CD8+ infltrate, and metastatic evolution. Materials and methods Eighty-three adnexal carcinomas were included. Immunohistochemistry using anti-PD-L1 mono- clonal antibodies (E1L3N and 22C3) and CD8 was performed. PD-L1 expression in tumor and immune cells, and CD8 + tumor-infltrating lymphocyte (TIL) density were analyzed semi-quantitatively. Results Among the 60 sweat gland, 18 sebaceous and 5 trichoblastic carcinomas, 11% expressed PD-L1 in ≥ 1% tumor cells, more frequently sweat gland carcinomas (13%, 8/60) including apocrine carcinoma (40%, 2/5) and invasive extramam- mary Paget disease (57%, 4/7). Immune cells expressed signifcantly more PD-L1 than tumor cells (p < 0.01). Dense CD8+ TILs were present in 60% trichoblastic, 43% sweat gland, and 39% sebaceous carcinomas. CD8+ TILs were associated with PD-L1 expression by tumor cells (p < 0.01). Thirteen patients out of 47 developed metastases (27%) with a median follow- up of 30.5 months (range 7–36). Expression of PD-L1 by tumor cells was associated with the development of metastasis in univariate analysis (HR 4.0, 95% CI 1.1–15, p = 0.0377) but not in multivariate analysis (HR 4.1, 95% CI 0.6–29, p = 0.15). Conclusion PD-L1 expression is highly heterogeneous among adnexal carcinoma subtypes, higher in apocrine carcinoma and invasive extramammary Paget disease, and associated with CD8 + TILs. Our data suggest the interest of evaluating anti- PD1 immunotherapy in advanced or metastatic cutaneous adnexal carcinoma. Keywords Cutaneous adnexal carcinoma · Programmed cell death ligand 1 (PD-L1) · Tumor-infltrating lymphocytes (TILs) · CD8 Abbreviations AJCC American Joint Committee on Cancer * Maxime Battistella [email protected] APHP Assistance Publique-Hôpitaux de Paris BCC Basal cell carcinoma 1 Pathology Department, INSERM UMR_S1165, Hôpital CHRU Centre hospitalier régional universitaire Saint Louis, Assistance Publique-Hôpitaux de Paris (APHP), cSCC Cutaneous squamous cell carcinoma 1 Avenue Claude Vellefaux, 75010 Paris, France EMPD Extramammary Paget disease 2 Dermatology Department, Hôpitaux universitaires de IC Immune cells Strasbourg, Strasbourg, France NOS No other specifcation 3 Dermatology Department, Centre Hospitalier Régional TC Tumor cells Universitaire (CHRU) de Lille, Lille, France TMB Tumor mutation burden 4 INSERM, Unité mixte de recherche (UMR)_S976, UMR Unité mixte de recherche University Paris Diderot, Paris, France WHO World Health Organization 5 Dermatology Department, Hôpital St Louis, APHP, Paris, France 6 INSERM, UMR_S1165, University Paris Diderot, Paris, France Vol.:(0123456789)1 3 952 Cancer Immunology, Immunotherapy (2019) 68:951–960 Introduction study. Diagnoses were performed according to the latest World Health Organization (WHO) criteria for skin can- Cutaneous adnexal carcinomas are a large and diverse cers, and validated in the French CARADERM (CAncers group of tumors, deriving from diferent types of adnexal RAres DERMatologiques—rare skin cancers) Network epithelium present in normal skin (sebaceous glands, (National Institute of Cancer). For all patients, there was apocrine glands, eccrine glands, and hair follicles) [1, enough formalin-fxed parafn embedded tumor mate- 2]. Their exact prevalence is unknown but these lesions rial remaining after the diagnosis had been established are rare in comparison to other skin cancers [3]. Some to qualify the samples for additional immunohistochemi- of the malignant adnexal tumors have high rates of local cal studies. All surgical samples of included patients were recurrence and distant metastases [4]: 20–25% of poro- taken at diagnosis, before any medical treatment of the carcinomas and as much as 50% digital papillary adeno- disease. Clinical data at diagnosis and follow-up data were carcinomas may recur or metastasize [5–8]. In cutaneous collected from clinical fles. Tumors were staged using the adnexal carcinomas, surgery is the only curative treatment, eighth TNM version of the American Joint Committee on and there is a lack of therapy for unresectable or meta- Cancer (AJCC) (2017), according to the recommendation static tumors: radiotherapy may be proposed for locally of the WHO 2018 classifcation of skin tumors. advanced tumors [9], whereas no consensus exists regard- ing management of metastatic cases, which remain an area of high unmet clinical need [10, 11]. Immunohistochemistry Programmed death-1 (PD-1) and its ligand (PD-L1) constitute an important immune checkpoint [12], play- Immunohistochemistry was performed according to the ing a major role in evasion of malignant tumor cells from following protocol: 3 μm parafn sections were placed on ® the immune system [13]. The prognostic value of PD-L1 Superfrost plus glass slides. PD-L1 expression was per- ® expression by tumor cells remains controversial. In some formed using a BenchMark Ultra automated immunostainer studies, it was reported as a marker of poor prognosis [14]. (Roche-Ventana, Basel, Switzerland) and monoclonal anti- On the contrary, in melanoma patients, PD-L1 expression bodies against PD-L1, E1L3N [1:200 dilution (Cell Signal- may be associated with better prognosis [15]. The predic- ing Technology, Danvers, MA, USA)] and 22C3 [1:50 dilu- tive value of PDL-1 expression by tumor cells for response tion (Dako, Hamburg, Germany)]. CD8 immunostaining was to anti-PD1/PD-L1 agents has been largely studied and performed using anti-CD8 4B11 clone [1:50 dilution (Dako, reported. In melanoma as in lung carcinoma, renal cell Hamburg, Germany)]. carcinoma and urothelial carcinoma, increased response rates, improved progression-free survival and overall sur- vival are observed in patients with higher PD-L1 tumor Microscopic evaluation expression [16]. To our knowledge, there is no report examining PD-L1 Immunostaining was assessed by two pathologists (M. Bat- expression in cutaneous adnexal carcinomas. In the con- tistella and L. Duverger) independently, blindly from follow- text of the potential use of anti-PD1/PD-L1 therapy in up data, when available. cutaneous adnexal carcinomas, we aimed here to deter- The immunohistochemical expression of PD-L1 was mine the expression pattern of PD-L1 in tumor cells and quantifed semi-quantitatively. Adnexal carcinomas were microenvironment immune cells in cutaneous adnexal divided as previously described into 4 groups according to carcinomas, and to analyze its association with the level the percentage of PD-L1 positive tumor cells: < 1% (TC0), of CD8+ tumor-infltrating lymphocytes (TIL) and with 1–4% (TC1), 5–49% (TC2) and > 50% (TC3), and into metastatic evolution. four groups according to the percentage of PD-L1 positive immune cells: < 1% (IC0), 1–4% (IC1), 5–10% (IC2) and > 10% (IC3) [17]. For subsequent analyses, tumors were considered to be Materials and methods PD-L1 (+) when ≥ 1% of tumor cells demonstrated mem- branous staining. Patients To evaluate CD8 + TIL, we used a semi-quantitative visual score: none (0), mild (1), moderate (2), or severe (3). The + Eighty three patients with cutaneous adnexal carcinoma degree of CD8 TIL infltration was evaluated into the tumor from a single University hospital (Hôpital Saint Louis) and in its stroma. Stromal TIL evaluation, which is more diagnosed between 2002 and 2018 were included in the reproducible, was further used for the association analysis with PD-L1 tumor cell expression [18, 19]. 1 3 Cancer Immunology, Immunotherapy (2019) 68:951–960 953 Statistical analyses Table 1 Patients’ characteristics Variable N (%) Continuous variables were described as medians (25th; 75th interquartile range) and dichotomous data as percent- Sex ages. Diferences in frequencies of quantitative variables Male 51 (62) were compared using the χ2 test with Pearson’s correction Female 32 (38) or a Fisher’s exact test when sample sizes were too small Age in years, median (range) 68 (26; 95) (expected values below 5). Fisher’s exact test was used Tumor type to compare the proportion of samples with CD8+ TIL in Sweat gland carcinoma 60 (72) PD-L1(+) and PD-L1(−) samples. As we had missing data Porocarcinoma 14 (17) for PD-L1 using 22C3 clone, we used preferentially E1L3N Hidradenocarcinoma 11 (13) antibody results for all the statistical tests of the study. Ductal adenocarcinoma NOS 10 (12) We evaluated the agreement between the PD-L1 results Microcystic adnexal carcinoma 5 (6) with the two antibodies (E1L3N and 22C3 clones) using Syringoid eccrine carcinoma 5 (6) Cohen’s weighted kappa (κ) statistic interpreted as follows: Apocrine carcinoma 5 (6) κ < 0.20, poor strength; κ = 0.21–0.40, fair; κ = 0.41–0.60, Invasive extramammary Paget disease 7 (8) moderate; κ = 0.61–0.80, good; κ = 0.81–1.00, very good. Digital
Load more

Recommended publications
  • H&N Grand Rounds
    H&N Grand Rounds December 2, 2011 Unusual Salivary Neoplasms Presentation, Diagnosis, Management Presenters Drs. Dario Kunar, Ray Blanco, Carole Fakhry Discussants Drs. Fred Yegeneh, Marshall Levine, Geoffrey Neuner, James Sciubba Case History Dr. Carole Fakhry CC: Palatal mass HPI: 42 year old female with a four-year history of unusual sensation in the mouth. On dental examination one year ago was noted to have an irregularity of hard palate. Upon follow-up examination, the mass was noted to be persistent and was biopsied. She has no other complaints and denies any symptoms. James J. Sciubba, DMD, PhD LF • Cc: • palate mass • HPI: • 42 year old female with a four-year history of unusual sensation in the mouth. • On dental examination one year ago was noted to have an irregularity of hard palate. • Upon follow-up examination, the mass was noted to be persistent and was biopsied. • She has no other complaints and denies any symptoms. James J. Sciubba, DMD, PhD LF • PMH: • Hodgkin’s Lymphoma- chemotherapy 20 years ago • Medication: none • NKDA • SH: 20 py, Etoh: heavy use James J. Sciubba, DMD, PhD Differential Diagnosis Clinical • Benign mixed tumor • Monomorphic adenoma • Mucoepidermoid carcinoma • Adenoid cystic carcinoma • PLGA • Metastatic breast carcinoma James J. Sciubba, DMD, PhD Imaging Dr. Fred Yegeneh LF LF LF Imaging Summary Treatment • Primary therapy is surgical • Extent of primary therapy is controversial in literature • Radiation reported, though rarely used • Long term surveillance • Local recurrence rate between 17-33%, regional recurrence 9-18% James J. Sciubba, DMD, PhD Pathology Cytologic Features • Cuboidal to columnar cells • Nuclei ovoid to elongated and bland • Vesicular to stippled chromatin • Indistinct cell borders • Rare mitotic figures James J.
    [Show full text]
  • Detection and Genomic Characterization of a Mammary-Like Adenocarcinoma
    Downloaded from molecularcasestudies.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press COLD SPRING HARBOR Molecular Case Studies | RESEARCH REPORT Detection and genomic characterization of a mammary-like adenocarcinoma Jasleen K. Grewal,1 Peter Eirew,2 Martin Jones,1 Kenrry Chiu,3 Basile Tessier-Cloutier,2,3 Anthony N. Karnezis,3 Aly Karsan,4 Andy Mungall,1 Chen Zhou,3 Stephen Yip,3 Anna V. Tinker,5 Janessa Laskin,5 Marco Marra,1 and Steven J.M. Jones1 1Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada; 2Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada; 3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; 4Genome Sciences Centre and Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada; 5Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada Abstract Whole-genome and transcriptome sequencing were performed to identify potential therapeutic strategies in the absence of viable treatment options for a patient initially diagnosed with vulvar adenocarcinoma. Genomic events were prioritized by com- parison against variant distributions in the TCGA pan-cancer data set and complemented with detailed transcriptome sequencing and copy-number analysis. These findings were considered against published scientific literature in order to evaluate the functional effects of potentially relevant genomic events. Analysis of the transcriptome against a background of 27 TCGA cancer types led to reclassification of the tumor as a primary HER2+ mammary- like adenocarcinoma of the vulva.
    [Show full text]
  • Parotid Adenoid Cystic Carcinoma: a Case Report and Review of The
    ancer C C as & e y Ilson et al., Oncol Cancer Case Rep 2015,1:1 g R o e l p o o c r t n Oncology and Cancer Case O ISSN: 2471-8556 Reports ResearchCase Report Article OpenOpen Access Access Parotid Adenoid Cystic Carcinoma: A Case Report and Review of the Literature Sepúlveda Ilson1*, Frelinghuysen Michael2, Platín Enrique3, Ortega Pablo4 and Delgado Carolina5 1Maxillofacial-Head and Neck Radiologist, ENT-Head and Neck Surgery Service, General Hospital of Concepcion, Chile 2Physician, Radiation Oncologist, Oncology Service, General Hospital of Concepcion, Chile 3Professor of Oral and Maxillofacial Radiology, University of North Carolina School of Dentistry, Chapel Hill, NC, USA 4Physician, Otolaryngologist, ENT-Head and Neck Surgery Service, General Hospital of Concepcion, Chile 5Physician Pathologist, Pathology Department, General Hospital of Concepción, University of Concepcion School of Medicine, Concepcion, Chile Abstract We report on a patient who presented to the ENT service with swelling of the right side of the parotid gland. The swelling had been present for four years. Imaging studies revealed an expansive process confined to the superficial right parotid lobule. The affected area was well delineated with irregular enhancement post intravenous contrast media administration. Surgical biopsy concluded the presence of Adenoid Cystic Carcinoma. The patient was treated with adjuvant radiation therapy and follow up exams confirm there is no evidence of recurrence. Introduction Adenoid cystic carcinoma (ACC) is malignant epithelial tumors that most commonly occur between the 5th and 6th decades of life. It is a slowly growing but highly invasive cancer with a high recurrence rate. This tumor has the propensity for perineural invasion.
    [Show full text]
  • Adenoid Cystic Carcinoma of the Head and Neck– Literature Review 311
    Quality in Primary Care (2015) 23 (5): 309-314 2015 Insight Medical Publishing Group Research Article AdenoidResearch Article Cystic Carcinoma of the Head and Open Access Neck– literature review Pinakapani R, MDS Department of Oral Medicine and Radiology, Genesis Institute of Dental Science and Research, Ferozepur, Punjab. Nallan CSK Chaitanya, MDS, Ph.D Department of Oral Medicine and Radiology, Panineeya Institute of Dental Sciences & Research Centre, Hyderabad Reddy Lavanya Senior Lecturer, Department of Oral Medicine and Radiology Panineeya Institute of Dental Sciences & Research Centre, Hyderabad Srujana Yarram Senior Lecturer, Department of Oral Medicine and Radiology Panineeya Institute of Dental Sciences & Research Centre, Hyderabad Mamatha Boringi Senior Lecturer, Department of Oral Medicine and Radiology Panineeya Institute of Dental Sciences & Research Centre, Hyderabad Shefali Waghray Department of Oral Medicine and Radiology, Panineeya Institute of Dental Sciences & Research Centre, Hyderabad AbStRACt Adenoid cystic carcinoma (ACC) is a rare salivary gland ACCs have a good five year survival rate. Nevertheless, overall malignant neoplasm. Clinically it represents as an indolent survival rate drops after 5-year followup period. yet a persistent lesion, which shows propensity for late distant This review paper attempts understanding ACC – it’s clinical metastases, involving vital tissues often leading to the death presentation, management and factors affecting prognosis. of the patient. Its innoceous clinical presentation remains a diagnostic challenge. Keywords: Adenoid cystic carcinoma; Malignant salivary gland neoplasm; Perineural invasion. Till date surgery and radiotherapy still remain the main course of treatment. Despite advanced successful therapies these tumors Key Messages : This review deals with recent concepts are notoriously associated with loco regional recurrences.
    [Show full text]
  • S1609 Faq Upcoming Dart Cohort Closures As of 28
    S1609 FAQ 1 UPCOMING DART COHORT CLOSURES AS OF 24-SEP-2021 6:10 AM Up-coming Closure Closure # COHORT Name Date Type 40 Peritoneal mesothelioma 10/06/2021 Temporary CLOSED DART COHORTS AS OF 24-SEP-2021 6:10 AM 2 REGS. REGS. REGS. REGS. REGS. LAST LAST LAST LAST LAST # of # of TOTAL 12 6 3 30 7 ACT. CURR Closure Type # COHORT NAME REGS. Month Month Month DAYS DAYS INSTs IRBs Permanent 1 Epithelial tumors of nasal cavity, sinuses, nasopharynx 7 0 0 0 0 0 337 150 Close Permanent 2 Epithelial tumors of major salivary glands 30 0 0 0 0 0 Close Permanent 3 Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location 6 0 0 0 0 0 Close Permanent 4 Undifferentiated carcinoma of gastrointestinal (GI) tract 6 1 0 0 0 0 Close Permanent 5 Adenocarcinoma with variants of small intestine 26 0 0 0 0 0 Close Permanent 6 Squamous cell carcinoma with variants of GI tract (stomach small intestine, colon, rectum, pancreas) 6 0 0 0 0 0 Close Permanent 7 Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary 10 0 0 0 0 0 Close Permanent 8 Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous 11 0 0 0 0 0 Close cystadenocarcinoma Permanent 9 Intrahepatic cholangiocarcinoma 9 0 0 0 0 0 Close Permanent 10 Extrahepatic cholangiocarcinoma and bile duct tumors 10 0 0 0 0 0 Close Permanent 13 Non-epithelial tumors of the ovary 25 0 0 0 0 0 Close Permanent 14 Trophoblastic tumor 3 0 0 0 0 0 Close Permanent 15 Transitional cell
    [Show full text]
  • Sinonasal Tract and Nasopharyngeal Adenoid Cystic Carcinoma: a Clinicopathologic and Immunophenotypic Study of 86 Cases
    Head and Neck Pathol DOI 10.1007/s12105-013-0487-3 ORIGINAL RESEARCH Sinonasal Tract and Nasopharyngeal Adenoid Cystic Carcinoma: A Clinicopathologic and Immunophenotypic Study of 86 Cases Lester D. R. Thompson • Carla Penner • Ngoc J. Ho • Robert D. Foss • Markku Miettinen • Jacqueline A. Wieneke • Christopher A. Moskaluk • Edward B. Stelow Received: 14 July 2013 / Accepted: 23 August 2013 Ó Springer Science+Business Media New York (outside the USA) 2013 Abstract ‘Primary sinonasal tract and nasopharyngeal (n = 44), with a mean size of 3.7 cm. Patients presented adenoid cystic carcinomas (STACC) are uncommon equally between low and high stage disease: stage I and II tumors that are frequently misclassified, resulting in inap- (n = 42) or stage III and IV (n = 44) disease. Histologi- propriate clinical management. Eighty-six cases of STACC cally, the tumors were invasive (bone: n = 66; neural: included 45 females and 41 males, aged 12–91 years (mean n = 47; lymphovascular: n = 33), composed of a variety 54.4 years). Patients presented most frequently with of growth patterns, including cribriform (n = 33), tubular obstructive symptoms (n = 54), followed by epistaxis (n = 16), and solid (n = 9), although frequently a com- (n = 23), auditory symptoms (n = 12), nerve symptoms bination of these patterns was seen within a single tumor. (n = 11), nasal discharge (n = 11), and/or visual symp- Pleomorphism was mild with an intermediate N:C ratio in toms (n = 10), present for a mean of 18.2 months. The cells containing hyperchromatic nuclei. Reduplicated tumors involved the nasal cavity alone (n = 25), naso- basement membrane and glycosaminoglycan material was pharynx alone (n = 13), maxillary sinus alone (n = 4), or commonly seen.
    [Show full text]
  • FNA of Tumors of Unknown Primary in the Head and Neck Jeffrey F
    FNA of Basaloid Neoplasms of the Head and Neck Jeffrey F. Krane, MD PhD Professor of Pathology David Geffen School of Medicine at UCLA Overview • Case based approach • Basaloid tumors and closely related entities • Review – Common clinical presentations – Cytologic features – Adjunctive techniques as appropriate Basaloid Tumors • Sparse cytoplasm confers an immature appearance • Need to rely on other clues to classify – Chromatin – Matrix – Architecture/Smear pattern – Non-basaloid areas Two Main Scenarios • Basaloid salivary gland tumors • Basaloid metastases in neck lymph nodes Salivary Gland Tumors Salivary gland neoplasms Clinical Management • Superficial parotid gland is most common site • Benign tumor/Low-grade carcinoma Excision of the mass (partial parotidectomy) • High-grade carcinoma Radical surgery (complete parotidectomy) Neck dissection? Radiation therapy Challenging Salivary Gland Patterns Benign/LG Malignant HG Malignant • Oncocytic/Clear cell • High-grade • Spindle cell • Cystic/Mucinous Basaloid neoplasms Basaloid pattern is most problematic Differential diagnosis spans benign, low-grade and high-grade carcinomas Case 1: History • A 79 year-old woman with a 5 month history of a firm, mobile 2 cm non-tender parotid mass. Case 1 Case 1 Case 1 Case 1 Case 1 Case 1 Case 1: Diagnosis? A. Adenoid cystic carcinoma B. Basal cell adenoma C. Skin adnexal neoplasm D. Basaloid squamous cell carcinoma Case 1 Case 1: Diagnosis? Basal cell adenoma, membranous type Basaloid neoplasms: Differential Diagnosis • Benign: Basal cell adenoma,
    [Show full text]
  • Molecular and Cellular Modelling of Salivary Gland Tumors Open New Landscapes in Diagnosis and Treatment
    cancers Review Molecular and Cellular Modelling of Salivary Gland Tumors Open New Landscapes in Diagnosis and Treatment Cristina Porcheri * , Christian T. Meisel and Thimios A. Mitsiadis Orofacial Development and Regeneration, Institute of Oral Biology, University of Zurich, Plattenstrasse 11, 8032 Zurich, Switzerland; [email protected] (C.T.M.); [email protected] (T.A.M.) * Correspondence: [email protected] Received: 4 October 2020; Accepted: 20 October 2020; Published: 24 October 2020 Simple Summary: This review elaborates the current knowledge on salivary gland tumors, with a specific focus on classical histological classification, cellular mechanisms and molecular pattern at the origin of the most common glandular malignancies. We dive into novel approaches for modeling, diagnosis and therapy, giving an overview of the biomedical advances for the study of salivary cancers. Thereby this review helps to understand the complexity of these malignancies and paves the way for novel and efficient treatments. Abstract: Salivary gland tumors are neoplasms affecting the major and minor salivary glands of the oral cavity. Their complex pathological appearance and overlapping morphological features between subtypes, pose major challenges in the identification, classification, and staging of the tumor. Recently developed techniques of three-dimensional culture and organotypic modelling provide useful platforms for the clinical and biological characterization of these malignancies. Additionally, new advances in genetic and molecular screenings allow precise diagnosis and monitoring of tumor progression. Finally, novel therapeutic tools with increased efficiency and accuracy are emerging. In this review, we summarize the most common salivary gland neoplasms and provide an overview of the state-of-the-art tools to model, diagnose, and treat salivary gland tumors.
    [Show full text]
  • Update in Salivary Gland Pathology
    Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives • Review the different appearances of a selection of salivary gland tumor types • Establish an immunohistochemical staining pattern to aid in distinguishing between certain tumors • Discuss some newer concepts in salivary gland pathology Acinic Cell Carcinoma • Originally this was considered a benign neoplasm until its malignant potential was described in the 1950s • Later regarded as in between adenoma and carcinoma (acinic cell tumor; WHO 1972) • Finally classified as acinic cell carcinoma in 1991 WHO classification • Diagnosis can be rendered in absence of invasive growth Acinic Cell Carcinoma • Third most common malignancy of major salivary gland (15%) • Most non-parotid ACC (11/14; 80%) actually represent misclassified mammary analogue secretory carcinoma (MASC) - Based upon positivity for S100, mammaglobin - Confirmatory ETV6 t(12;15) translocation by FISH Bishop et al. Am J Surg Pathol. 2013;37(7): 1053-57 Acinic Cell Carcinoma • Neoplasm of cells differentiated towards serous acinar cells • Aside from the zymogen granule rich cells (pathognomonic acinar cells) other cell types frequent these tumors: - Vacuolated cells - Clear cells (non-mucinous, PAS negative) - Nonspecific glandular cells • No grading system exists although high grade transformation is reported Lesion 1: Parotid Mass in 68 year old female Lesion 1: Note clear and vacuolated cells Lesion 2: Parotid mass (3 cm) in 15 year old female PAS-D on Lesion
    [Show full text]
  • 2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors
    International Journal of Molecular Sciences Review 2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors Malin Tordis Meyer 1, Christoph Watermann 1, Thomas Dreyer 2, Süleyman Ergün 3 and Srikanth Karnati 3,* 1 Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Klinikstrasse 33, Ebene -1, 35392 Giessen, Germany; [email protected] (M.T.M.); [email protected] (C.W.) 2 Institute for Pathology, Justus Liebig University, Langhansstrasse 10, 35392 Gießen, Germany; [email protected] 3 Institute for Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Koellikerstrasse 6, 97070 Würzburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-931-3181522 Abstract: Salivary gland tumors are a rare tumor entity within malignant tumors of all tissues. The most common are malignant mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Pleomorphic adenoma is the most recurrent form of benign salivary gland tumor. Due to their low incidence rates and complex histological patterns, they are difficult to diagnose accurately. Malignant tumors of the salivary glands are challenging in terms of differentiation because of their variability in histochemistry and translocations. Therefore, the primary goal of the study was to review the current literature to identify the recent developments in histochemical diagnostics and translocations for differentiating salivary gland tumors. Keywords: salivary gland tumors; epithelial salivary gland; adenoid cystic carcinoma (ACC); Citation: Meyer, M.T.; pleomorphic adenoma; mucoepidermoid carcinoma; diagnostic markers Watermann, C.; Dreyer, T.; Ergün, S.; Karnati, S. 2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors. Int.
    [Show full text]
  • Primary Adenoid Cystic Carcinoma of the Peripheral Lungs
    J UOEH 37（ 2 ）: 121－125（2015） 121 ［Case Report］ Primary Adenoid Cystic Carcinoma of the Peripheral Lungs Shinji Shinohara*, Takeshi Hanagiri, Masaru Takenaka, Soichi Oka, Yasuhiro Chikaishi, Hidehiko Shimokawa, Makoto Nakagawa, Hidetaka Uramoto, Tomoko So and Fumihiro Tanaka Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Japan. Yahatanishi-ku, Kitakyushu 807-8555, Japan Abstract : We herein report a very rare case of adenoid cystic carcinoma of the peripheral lungs. A 77-year-old female visited a family physician for aortitis syndrome, diabetes mellitus and hyperlipidemia. A follow-up chest computed tomography scan for aortitis syndrome revealed a nodule in the middle lobe of the right lung. Although a transbronchial lung biopsy was attempted, a definitive diagnosis could not be made. Because the possibility of lung malignancy could not be ruled out, thoracoscopic wedge resection of the middle lobe was performed. The intraop- erative pathological diagnosis revealed carcinoma of the lungs and we performed middle lobectomy under complete video-assisted thoracoscopic surgery. A histopathological examination demonstrated an adenoid cystic carcinoma with a characteristic cribriform structure. Keywords : adenoid cystic carcinoma, peripheral lung, primary lung cancer, video-assisted thoracoscopic surgery. （Received February 18, 2015, accepted April 30, 2015） Introduction Case Adenoid cystic carcinoma (ACC) is a distinctive A 77-year-old female visited a family physician type of malignant epithelial neoplasm that commonly with aortitis syndrome, diabetes mellitus and hyper- arises in the salivary glands [1]. ACC of the lungs is a lipidemia. A follow-up chest computed tomography relatively rare lung cancer that originates in the bron- (CT) scan for aortitis syndrome revealed a nodule in chial glands, accounting for approximately 0.04-0.2% the middle lung, and she was referred to our hospi- of all lung cancers [2, 3].
    [Show full text]
  • Primary Cutaneous Adenoid Cystic Carcinoma: a Case Report and Review of the Literature
    Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Review of the Literature Jennifer Barnes, MD; Carlos Garcia, MD Primary cutaneous adenoid cystic carcinoma is x-ray were normal. Serum carcinoembryonic antigen a rare cancer, with only 61 cases reported in levels were within reference range. The lesion was the literature. We report an additional case and treated with Mohs micrographic surgery and tumor- review the latest recommendations for workup free margins were achieved in 2 stages. The defect and treatment. was repaired with a rotation flap. The patient was Cutis. 2008;81:243-246. recurrence free at 6-month follow-up. Comment Adenoid cystic carcinoma can arise from a vari- Case Report ety of primary sites, including the salivary glands, A 62-year-old woman presented to her dermatolo- respiratory tract, cervix, vulva, breast, thymus, gist with several months’ history of a painless nodule prostate, external auditory canal, esophagus, and on the scalp. The patient had a prior medical his- skin.1,2 Adenoid cystic carcinoma most commonly tory of hypertension and osteoporosis. Results of a presents in the major and minor salivary glands, physical examination revealed a hard, 20311-mm, so primary adenoid cystic carcinoma of the major pink and flesh-colored lesion in the mid- and minor salivary glands must be ruled out. In line parietal region of the scalp with alopecia general, adenoid cystic carcinoma can have late- over the nodule (Figure 1). Results of a shave occurring metastasis, involving regional nodes, biopsy stained with hematoxylin and eosin was lungs, bone, and brain, but cutaneous metastasis diagnostic of primary cutaneous adenoid cystic from a primary head and neck adenoid cystic car- carcinoma (Figure 2).
    [Show full text]